These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1291007)

  • 1. Guidelines for the identification, investigation and treatment of individuals with concomitant tuberculosis and human immunodeficiency virus infection. Canadian Thoracic Society, the Tuberculosis Directors of Canada and the Department of National Health and Welfare.
    Can Commun Dis Rep; 1992 Oct; 18(20):155-60. PubMed ID: 1291007
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for the investigation of individuals who were place under surveillance for tuberculosis post-landing in Canada. Canadian Thoracic Society, the Tuberculosis Directors of Canada and the Department of National Health and Welfare.
    CMAJ; 1993 Jun; 148(11):1957-60. PubMed ID: 8500032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for the identification, investigation and treatment of individuals with concomitant tuberculosis and HIV infection. Bureau of Communicable Disease Epidemiology, Canada Department of National Health and Welfare.
    CMAJ; 1993 Jun; 148(11):1963-70. PubMed ID: 8500033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines for the investigation of individuals who were placed under surveillance for tuberculosis post-landing in Canada. Immigration and Overseas Health Services and the Bureau of Communicable Disease Epidemiology.
    Can Commun Dis Rep; 1992 Oct; 18(20):153-5. PubMed ID: 1291006
    [No Abstract]   [Full Text] [Related]  

  • 5. Chapter 4: childhood contact screening and management.
    World Health Organization Stop TB Partnership Childhood TB Subgroup
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):12-5. PubMed ID: 17217124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active tuberculosis in individuals infected with human immunodeficiency virus after isoniazid prophylaxis.
    Fitzgerald DW; Morse MM; Pape JW; Johnson WD
    Clin Infect Dis; 2000 Dec; 31(6):1495-7. PubMed ID: 11096020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CDC calls for tuberculosis screening and treatment for all patients with HIV infection.
    Rose VL
    Am Fam Physician; 1999 Mar; 59(6):1682, 1687. PubMed ID: 10193602
    [No Abstract]   [Full Text] [Related]  

  • 8. Community responses to HIV/TB in Canada: a discussion of issues addressed in the HIV/TB Project of the Canadian AIDS Society.
    Zack E
    Int J Tuberc Lung Dis; 2000 Feb; 4(2 Suppl 1):S49-54. PubMed ID: 10688149
    [No Abstract]   [Full Text] [Related]  

  • 9. Tuberculosis prophylaxis in HIV infection.
    Trevett A; Temu P; Naraqi S
    P N G Med J; 1993 Sep; 36(3):256. PubMed ID: 8059554
    [No Abstract]   [Full Text] [Related]  

  • 10. Tuberculosis with human immunodeficiency virus infection.
    Cherian T; Verghese VP
    Indian J Pediatr; 2000 Feb; 67(2 Suppl):S47-52. PubMed ID: 11129908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis in developing countries.
    Porter JD
    CDR (Lond Engl Rev); 1991 Nov; 1(12):R136-9. PubMed ID: 1669756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoniazid preventive therapy in human immunodeficiency virus-infected persons. Long-term effect on development of tuberculosis and survival.
    Moreno S; Miralles P; Diaz MD; Baraia J; Padilla B; Berenguer J; Alberdi JC
    Arch Intern Med; 1997 Aug 11-25; 157(15):1729-34. PubMed ID: 9250234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional status of persons with HIV infection, persons with HIV infection and tuberculosis, and HIV-negative individuals from southern India.
    Swaminathan S; Padmapriyadarsini C; Sukumar B; Iliayas S; Kumar SR; Triveni C; Gomathy P; Thomas B; Mathew M; Narayanan PR
    Clin Infect Dis; 2008 Mar; 46(6):946-9. PubMed ID: 18279043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
    Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis and HIV infection.
    Malone JL; Paparello SF; Malone JD; Hill HE; Myers JW; Weiss P
    Lancet; 1993 Sep; 342(8872):677. PubMed ID: 8103159
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevention of tuberculosis in HIV-infected patients.
    Nahid P; Daley CL
    Curr Opin Infect Dis; 2006 Apr; 19(2):189-93. PubMed ID: 16514345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis preventive therapy in HIV-infected individuals.
    Bull World Health Organ; 1994; 72(2):305-7, 309-11. PubMed ID: 8205650
    [No Abstract]   [Full Text] [Related]  

  • 18. Tuberculosis and HIV infection.
    Bevilacqua N; Marasca G; Moscati A; Fantoni M; Ricci F; Ortona L
    Lancet; 1993 Sep; 342(8872):677. PubMed ID: 8103158
    [No Abstract]   [Full Text] [Related]  

  • 19. Questions about a placebo-controlled trial of preventive therapy for tuberculosis in HIV-infected Ugandans.
    Turner MT
    N Engl J Med; 1998 Mar; 338(12):841-2. PubMed ID: 9508640
    [No Abstract]   [Full Text] [Related]  

  • 20. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
    Kaplan JE; Hu DJ; Holmes KK; Jaffe HW; Masur H; De Cock KM
    Am J Trop Med Hyg; 1996 Jul; 55(1):1-11. PubMed ID: 8702012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.